Concepedia

Diana Andrew

DA

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2023

Affiliations

The Netherlands Cancer Institute(Current)

Diana Andrew is an author at The Netherlands Cancer Institute specializing in bispecific antibodies, pd-l1 blockade, and programmed death-ligand 1 inhibition.

Publications per year

2023–2023

1

Publications

1

1313MO Safety and preliminary efficacy of AZD7789, a bispecific antibody targeting PD-1 and TIM-3, in patients (pts) with stage IIIB–IV non-small-cell lung cancer (NSCLC) with previous anti-PD-(L)1 therapy

Benjamin Besse, Antoine Italiano, Sophie Cousin et al. · Annals of Oncology · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacology +16

1–1 of 1